Related Experiment Video
Updated: Jun 8, 2026
06:49
Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
Itraconazole pulse therapy in onychomycosis
1From the Department of Dermatology and Department of Microbiology, V.S.S. Medical College, Burla, Sambalpur 768 017, India, .
Indian Journal of Dermatology, Venereology and Leprology
|October 6, 2010
Summary
Itraconazole pulse therapy offers an effective and cost-efficient treatment for onychomycosis (fungal nail infection). This approach demonstrated sustained clinical and mycological success in patients over a 12-month period.
Area of Science:
- Dermatology
- Mycology
- Pharmacology
Background:
- Onychomycosis is a common fungal nail infection causing cosmetic and sometimes painful issues.
- Continuous oral antifungal therapy can lead to side effects and adherence challenges.
Purpose of the Study:
- To evaluate the efficacy and cost-effectiveness of itraconazole pulse therapy for onychomycosis.
- To assess clinical and mycological outcomes of itraconazole pulse therapy.
Main Methods:
- A prospective study involving 30 patients diagnosed with onychomycosis.
- Patients received itraconazole pulse therapy (1 week on, 3 weeks off) for 3-4 months.
- Clinical and mycological assessments were performed over a 12-month follow-up period.
Main Results:
- The study showed encouraging results with itraconazole pulse therapy.
- Patients achieved clinical and mycological clearance or marked improvement.
- The treatment demonstrated sustained efficacy and cost-effectiveness compared to continuous therapy.
Conclusions:
- Itraconazole pulse therapy is a viable and effective treatment for onychomycosis.
- This regimen offers a cost-effective alternative to continuous antifungal medication.
- The pulse therapy approach ensures sustained treatment efficacy for fungal nail infections.
Related Concept Videos
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:20Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications